once again layered on top of background therapy, which is expected to read out in the first half of 2025. The main endpoint in that study is MADRS scores compared to placebo at six weeks.

We summarized the recent progress in the research of hepatoprotective and molecular mechanisms of different flavonoids bioactive ingredients and also outlined the networks of underlying molecular ...

Clarametyx Biosciences, Inc, a biotechnology company developing targeted, immune-enabling biologic therapies to counter serious infections associated with biofilms, announced that it has completed the ...

It's common for clients to feel uncertain about their therapy progress. Empower them with these strategies: - Validate their feelings and reassure them that it's normal to experience doubt during ...

Introduce new or modified therapeutic techniques that might reignite interest and engagement. - Encourage self-compassion and acknowledge progress made, however small, to build confidence.

In a compelling interview, Thomas Moore, a distinguished author, psychotherapist, theologian, and former monk, delved into his unique approach to psychotherapy. Moore, renowned for his bestselling ...